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Adipokines, such as nicotinamide phosphoribosyltransferase (NAMPT), are molecules, which are produced in adipose tissue.
Recent studies suggest that NAMPT might also be produced in the tooth-supporting tissues, that is, periodontium, which also
includes the gingiva. The aim of this study was to examine if and under what conditions NAMPT is produced in gingival
fibroblasts and biopsies from healthy and inflamed gingiva. Gingival fibroblasts produced constitutively NAMPT, and this synthesis
was significantly increased by interleukin-1𝛽 and the oral bacteria P. gingivalis and F. nucleatum. Inhibition of the MEK1/2 and
NF𝜅B pathways abrogated the stimulatory effects of F. nucleatum on NAMPT. Furthermore, the expression and protein levels
of NAMPT were significantly enhanced in gingival biopsies from patients with periodontitis, a chronic inflammatory infectious
disease of the periodontium, as compared to gingiva fromperiodontally healthy individuals. In summary, the present study provides
original evidence that gingival fibroblasts produce NAMPT and that this synthesis is increased under inflammatory and infectious
conditions. Local synthesis of NAMPT in the inflamed gingiva may contribute to the enhanced gingival and serum levels of
NAMPT, as observed in periodontitis patients. Moreover, local production of NAMPT by gingival fibroblasts may represent a
possible mechanism whereby periodontitis may impact on systemic diseases.
1. Introduction
Periodontitis is a chronic inflammatory disease, which is
characterized by the irreversible destruction of the tooth-
supporting tissues, that is, periodontium. The periodontium
consists of the gingiva, periodontal ligament (PDL), root
cementum, and alveolar bone. Periodontopathogens, such as
Porphyromonas gingivalis and Fusobacterium nucleatum, in
the subgingival dental plaque are essential for the initiation
and progression of periodontitis [1, 2]. However, cofactors,
such as smoking or genetic predisposition, are also critical
and represent established risk factors of periodontitis [3].The
periodontopathogens and their components and products
can elicit an inflammatory host response, which involves
inflammatory mediators, such as interleukin (IL)-1𝛽, in the
periodontal tissues. The inflammation, if exaggerated, can
lead to matrix degradation and bone resorption and, thereby,
formation of periodontal pockets. If periodontitis remains
untreated, the disease can finally result in tooth loss [3, 4].
Periodontitis is one of the most frequent diseases worldwide
and can have a tremendous impact on the physical, psycho-
logical, and social aspects of life [5, 6].
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Interestingly, several meta-analyses have revealed that
periodontitis is associated with obesity, diabetes type II, and
metabolic syndrome [7–10]. Even though the underlying
mechanisms for these associations are yet to be determined,
it has been speculated that adipokines might represent
an important pathomechanistic link between periodontitis
and the aforementioned systemic diseases [11]. Adipokines,
such as nicotinamide phosphoribosyltransferase (NAMPT),
leptin, resistin, and adiponectin, are molecules, which are
produced in adipose tissue [12]. However, there is increas-
ing evidence that these adipokines are also synthesized in
nonadipose tissues. In addition to their role in metabolic reg-
ulation, adipokines also modulate inflammatory and wound
healing processes.Whereas NAMPT, leptin, and resistin have
been shown to exert proinflammatory effects, adiponectin
seems to be anti-inflammatory under most circumstances
[13]. It has been suggested that the increased serum levels
of proinflammatory adipokines, as found in a number of
systemic diseases, could make affected individuals more
susceptible to periodontitis [14–17].
NAMPT is mainly synthesized by macrophages and
adipocytes in the adipose tissue and stimulates activation
of nuclear factor-kappaB (NF𝜅B) as well as production of
inflammatory molecules [18]. In obesity, metabolic syn-
drome, type 2 diabetes, and atherosclerosis, serum levels of
NAMPT are increased [14–17]. Interestingly, NAMPT has
also been found in gingival crevicular fluid (GCF) [19–
21]. Even more importantly, the levels of NAMPT in GCF
were significantly increased at inflamed sites, suggesting that
NAMPT is also produced locally in the periodontium [19–
21]. Recently, we have found that NAMPT is synthesized in
PDL cells and that the constitutive production of NAMPT
in these cells can be upregulated by inflammatory and
microbial signals [22, 23]. Furthermore, NAMPT induced
the production of proinflammatory and matrix-degrading
molecules and also interfered with the regenerative capacity
of PDL cells [23, 24]. These studies suggested that PDL
cells can contribute to the increased NAMPT levels in GCF
in periodontitis. However, whether other periodontal cells,
such as gingival fibroblasts, which are much more exposed
to periodontopathogens than PDL cells, also produce this
proinflammatory adipokine, is as yet unknown. The aim of
the present study was therefore to examine if, and under
what conditions, NAMPT is produced in human gingival
fibroblasts (HGF) and biopsies from healthy and inflamed
gingiva.
2. Materials and Methods
2.1. Culture and Treatment of Cells. HGF were obtained
from healthy gingiva of 8 individuals (mean age: 21.0 ±
1.6 years, min–max: 16–31 years; gender: 6 male/2 female),
who had to undergo wisdom teeth extraction in the Depart-
ment of Oral Surgery of the University of Bonn. Written
informed consent and approval of the Ethics Committee of
the University of Bonn were obtained (#043/11). HGF were
grown in Dulbecco’s minimal essential medium (DMEM,
Invitrogen, Karlsruhe, Germany) supplemented with 10%
fetal bovine serum (FBS, Invitrogen), 100 units penicillin, and
100 𝜇g/mL streptomycin (Invitrogen) at 37∘C in a humidified
atmosphere of 5% CO
2
. Cells from passages 3 to 5 were
seeded (50,000 cells/well) on cell culture plates and grown
to 80% confluence. One day prior to the experiment, the
FBS concentration was reduced to 1%. In order to simulate
inflammatory conditions in vitro, HGF were exposed to
IL-1𝛽 (0.2–5 ng/mL; Calbiochem, San Diego, CA, USA), as
done in our previous studies [25–27]. In order to mimic an
infectious environment in vitro, HGF were incubated with
the inactivated oral periodontopathogens Porphyromonas
gingivalis ATCC 33277 and Fusobacterium nucleatum ATCC
25586 (optical density: 0.025, 0.05, and 0.1). Bacteriawere sus-
pended in PBS (OD
660 nm = 1, equivalent to 1.2 × 10
9 bacterial
cells/mL) and exposed two times to ultrasonication (160W
for 15min) resulting in a complete killing, as previously
reported [22, 23]. In some experiments, cells were also pre-
incubated with specific inhibitors against NF𝜅B (pyrrolidine
dithiocarbamate, PDTC; 10 𝜇M; Calbiochem) and MEK1/2
(U0126; 10 𝜇M; Calbiochem) signaling pathways 1 h prior to
experiments.
2.2. Gingival Biopsies. Human gingiva was obtained from 10
periodontally healthy donors (mean age: 23.6 ± 1.7 years,
min–max: 18–36 years; gender: 3 male/7 female), 10 gingivitis
subjects (mean age: 31.4 ± 4.7 years, min–max: 17–66 years;
gender: 7 male/3 female), and 10 periodontitis patients (mean
age: 56.7 ± 5.5 years, min–max: 29–81 years; gender: 7 male/3
female). Exclusion criteria were presence of systemic diseases
or medications as well as smoking. Sites were categorized
into three groups according to the gingival index (GI),
probing pocket depth (PD), clinical attachment level (CAL),
and radiographic bone loss. Periodontally healthy sites were
characterized by GI = 0 (no clinical inflammation), PD ≤
3mm, no CAL, and no radiographic bone loss. Sites with
gingivitis had a GI > 1 (clinical inflammation), but also no
periodontal pockets, attachment loss, and radiographic bone
loss. Sites of periodontitis had also a GI > 1 and, additionally,
PD ≥ 5mm, CAL ≥ 3mm, and radiographic bone loss.
Gingivawas harvested duringwisdom teeth removals or teeth
extractions for orthodontic or periodontal reasons in the
Department of Oral Surgery of the University of Bonn. Writ-
ten informed consent and approval of the Ethics Committee
of the University of Bonn were obtained (#043/11).
2.3. Real-Time PCR. RNA was extracted with an RNA
extraction kit (Qiagen, Hilden, Germany). A total of 1 𝜇g
of RNA was reverse transcribed using iScriptTM Select
cDNA Synthesis Kit (Bio-Rad Laboratories, Munich, Ger-
many) at 42∘C for 90min followed by 85∘C for 5min.
The expression of NAMPT, adiponectin (Adipo) and its
receptors (AdipoR1 and AdipoR2), leptin and its functional
receptor (LeptinR), resistin, and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) was detected by real-time PCR
using the iCycler iQdetection system (Bio-RadLaboratories),
SYBR Green (Bio-Rad Laboratories), and specific primers
(QuantiTect Primer Assay, Qiagen). One 𝜇L of cDNA was
amplified as a template in a 25𝜇L reactionmixture containing
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12.5 𝜇L 2x QuantiFast SYBR Green PCR Master Mix (Qia-
gen), 2.5 𝜇L of primers, and deionized water. The mixture
was heated initially at 95∘C for 5min and then followed by
40 cycles with denaturation at 95∘C for 10 s and combined
annealing/extension at 60∘C for 30 s. GAPDH was used
as an endogenous control. The data were analyzed by the
comparative threshold cycle method.
2.4. ELISA. The levels of NAMPT in the supernatants of
HGF were determined by a commercially available ELISA
kit (RayBiotech, Norcross, GA, USA) according to the man-
ufacturer’s instructions. The absorbance was measured with
a microplate reader (PowerWave X, BioTek Instruments,
Winooski, VT, USA) at 450 nm. The data were normalized
by the cell number measured with an automatic cell counter
(Moelab, Hilden, Germany).
2.5. Immunocytochemistry. HGF were grown in the presence
and absence of IL-1𝛽, P. gingivalis, or F. nucleatum on glass
coverslips (Carl Roth, Karlsruhe, Germany) in 24-well plates
for 48 h. Afterwards, cells were fixed in 4% paraformaldehyde
(Sigma-Aldrich, Munich, Germany) at pH 7.4 and room
temperature (RT) for 10min and then permeabilized in
0.1% Triton X-100 (Sigma-Aldrich) for 5min. Nonspecific
antigenswere blocked by incubationwith serumblock (Dako,
Hamburg, Germany) for 20min. Cells were then incubated
with rabbit polyclonal antibody to NAMPT (Santa Cruz
Biotechnology, Santa Cruz, CA, USA; 1 : 50) at 4∘C overnight.
Subsequently, cells were labeled with goat anti-rabbit IgG-
HRP secondary antibody (Dako) for 30min. For staining,
cells were exposed to DAB chromogen (Thermo Fisher
Scientific, Waltham, MA, USA) for 10min at RT in the
dark. After each incubation step, cells were washed twice
with PBS (Invitrogen). Counterstaining was performed with
Mayer’sHematoxylin (Merck Eurolab, Dietikon, Switzerland)
for 1min. Coverslips were mounted in Aquatex mounting
agent (Merck Eurolab). Standardized photomicrographswere
taken using an Axioskop 2 microscope (Carl Zeiss, Jena,
Germany).The images were captured with an AxioCamMRc
camera (Carl Zeiss) and the AxioVision 4.7 software (Carl
Zeiss).
2.6. H&E Staining and Immunohistochemistry. Gingival
biopsies were fixed in 4% paraformaldehyde (Sigma-Aldrich)
for 2 days. Subsequently, the tissues were hydrated, then
dehydrated in an ascending ethanol series (AppliChem,
Darmstadt, Germany), and finally embedded in paraffin
(McCormick Scientific, Richmond, IL, USA). Tissue sections
of 2.5 𝜇m thickness were obtained, mounted on glass slides
(Carl Roth), and dried at 37∘C overnight. Sections from
healthy and inflamed gingival tissues were stained with
hematoxylin and eosin (H&E; Merck Eurolab). Selected
tissue sections were then deparaffinized, rehydrated, and
rinsed in PBS (Invitrogen) for 2min. Endogenous peroxidase
was blocked in 0.3% methanol (AppliChem)/H
2
O
2
(Merck
Eurolab) solution for 5min in the dark. After rinsing, sections
were pretreated with serum block (Dako) for 20min. Then,
sections were incubated with rabbit polyclonal antibody to
NAMPT (Santa Cruz Biotechnology, 1 : 200) in a humid
chamber at 4∘C overnight. For detection of the antibody
binding, sections were washed and then incubated with goat
anti-rabbit IgG-HRP secondary antibody (Dako) at RT for
30min. After rinsing, peroxidase activity was visualized with
DAB chromogen (Thermo Fisher Scientific). Subsequently,
all slides were rinsed and then counterstained with Mayer’s
hematoxylin (Merck Eurolab) for 1min, dehydrated, and cov-
erslipped for light microscopical analysis. Standardized pho-
tomicrographs were taken using an Axioskop 2 microscope
(Carl Zeiss). The images were captured with an AxioCam
MRc camera and the AxioVision 4.7 software (Carl Zeiss).
2.7. Statistical Analysis. For statistical analysis, the IBM SPSS
Statistics 20 software was used. Mean values and standard
errors of the mean (SEM) were calculated. All experiments
were performed in triplicate and repeated at least twice.
Parametric (ANOVA followed by the post hoc Dunnett test)
and nonparametric (Mann-Whitney 𝑈) tests were applied.
Differences between groups were considered significant at
𝑃 < 0.05.
3. Results
3.1. Regulation of NAMPT mRNA Expression in HGF. First,
we sought to examine whether HGF express NAMPT and,
if so, whether the constitutive expression of NAMPT is
modulated by inflammatory ormicrobial signals. As shown in
Figure 1(a), HGF expressed spontaneously NAMPT and this
expression was significantly enhanced by IL-1𝛽, P. gingivalis,
and F. nucleatum at 12 and 24 h. Further experiments revealed
that the stimulatory effect of IL-1𝛽 on theNAMPT expression
was dose-dependent, that is, the strongest upregulation of
NAMPT was observed at the highest concentration of IL-1𝛽
(Figure 1(b)). By contrast, only a slight dose-dependency was
found for the stimulatory action of F. nucleatum (Figure 1(c))
and no dose-dependency was observed for the effect of P.
gingivalis (data not shown) on NAMPT. Preincubation of
HGF with specific inhibitors against MEK1/2 and NF-𝜅B
signaling reduced the F. nucleatum-induced upregulation of
NAMPT by 64% and 83%, respectively.
3.2. Regulation of Adiponectin, Leptin, and Resistin mRNA
Expressions in HGF. We also sought to study whether
HGF produce additional adipokines and, if so, whether
their expression can be regulated by IL-1𝛽, P. gingivalis,
and F. nucleatum. Our experiments demonstrated that
HGF also express constitutively adiponectin, leptin, and
resistin (Figure 1(d)). However, the constitutive expression
of adiponectin was almost 200-fold and the constitutive
expression of leptin and resistin was even 1000-fold less
than that of NAMPT (data not shown). In general, IL-1𝛽, P.
gingivalis, and F. nucleatum had no significant effects on these
adipokines except for the P. gingivalis-induced upregulation
of resistin at 12 h (Figure 1(d)).
3.3. Regulation of NAMPT Protein Synthesis in HGF. The
significant upregulation of NAMPT expression by IL-1𝛽,
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Figure 1: Expression of NAMPT and other adipokines in HGF. (a) Upregulation of NAMPT mRNA expression by IL-1𝛽, P. gingivalis (Pg),
and F. nucleatum (Fn) in HGF from 8 donors at 12 h and 24 h. (b) Stimulation of NAMPT mRNA expression by various concentrations (0.2,
1.0, and 5.0 ng/mL) of IL-1𝛽 in HGF from 3 donors at 12 h. (c) Stimulation of NAMPTmRNA expression by various doses (OD: 0.025, 0.050,
and 0.100) of F. nucleatum in HGF from 3 donors at 12 h. (d) Expression of adiponectin, leptin, and resistin in IL-1𝛽-, P. gingivalis- (Pg-), and
F. nucleatum- (Fn-) treated HGF from 6 donors. Mean ± SEM; ∗significantly (𝑃 < 0.05) different from control.
P. gingivalis, and F. nucleatum was paralleled by increased
NAMPT protein levels in the supernatants of stimulated cells,
as compared to control cells, at 24 h and 48 h (Figure 2(a) and
Table 1). Enhanced protein levels of NAMPT were also found
in IL-1𝛽- and F. nucleatum-stimulated cells by immunocyto-
chemistry at 48 h (Figure 2(b)). By contrast, immunostaining
forNAMPTwas only slightly increased inP. gingivalis-treated
cells at this time point (Figure 2(b)).
3.4. Expression of NAMPT and Other Adipokines in Gingival
Biopsies. Next we studied the expression of NAMPT as well
as other adipokines and their receptors in gingival biop-
sies from periodontally healthy, gingivitis, and periodontitis
subjects. As demonstrated in Figure 3, the expression of
Table 1: Regulation ofNAMPTprotein levels, as analyzed by ELISA.
Group NAMPT (ng/10
6 cells)
24 h 48 h
Control 0.66 ± 0.10 0.65 ± 0.07
IL-1𝛽 5.85 ± 0.77∗ 7.27 ± 1.09∗
P. gingivalis 14.35 ± 3.01∗ 14.99 ± 2.37∗
F. nucleatum 17.00 ± 2.87∗ 8.86 ± 1.28∗
NAMPT protein levels in supernatants from IL-1𝛽-, P. gingivalis-, and F.
nucleatum-stimulated HGF (6 donors) at 24 h and 48 h. Untreated cells
served as control. Mean ± SEM; ∗significantly (𝑃 < 0.05) different from
control.
NAMPT was significantly enhanced in gingiva from peri-
odontitis patients as compared to gingiva from periodontally
healthy subjects. Moreover, the expression of resistin was
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Figure 2: NAMPT protein levels in HGF. (a) NAMPT protein levels in supernatants of IL-1𝛽-, P. gingivalis- (Pg-), and F. nucleatum- (Fn-
) stimulated HGF from 3 donors at 24 h and 48 h. Mean ± SEM; ∗significantly (𝑃 < 0.05) different from control. (b) NAMPT protein in
HGF in the presence and absence of IL-1𝛽, P. gingivalis, and F. nucleatum at 48 h, as analyzed by immunocytochemistry. Images from one
representative donor are shown.
significantly increased in gingivitis and periodontitis. In
contrast to NAMPT and resistin, leptin and adiponectin
expressions were significantly reduced in gingiva from peri-
odontitis patients. Interestingly, the downregulation of leptin
and adiponectin was paralleled by a significant upregulation
of their receptors in gingival biopsies from periodontitis
subjects (Figure 3).
3.5. NAMPT Protein in Gingival Biopsies. As shown in Fig-
ures 4(a)–4(c), healthy gingiva showed only few immunoin-
flammatory cells, whereas a pronounced round cell infiltrate
was observed in biopsies from gingivitis and periodontitis
subjects, as analyzed by hematoxylin and eosin staining.
In healthy gingiva, NAMPT was mainly localized in the
upper and intermediate layers of the epithelium, as evidenced
by immunohistochemistry (Figure 4(d)). Interestingly, no
immunolabeling was found in the epithelial basal layer
and in the subepithelial connective tissue. Similar findings
were observed in biopsies from gingivitis subjects. However,
some weak immunolabeling was additionally present in the
subepithelial connective tissue (Figure 4(e)). In gingiva from
periodontitis patients, NAMPT was diffusely distributed in
all layers of the epithelium (Figure 4(f)). Moreover, NAMPT
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Figure 3: Expression of NAMPT and other adipokines in gingival biopsies. Expression of NAMPT, adiponectin (Adipo) and its receptors
(AdipoR1 and AdipoR2), leptin and its receptor (LeptinR), and resistin in gingival biopsies from 10 periodontally healthy donors, 10 gingivitis
subjects, and 10 periodontitis patients. H: healthy donors; G: gingivitis subjects; P: periodontitis patients. Mean ± SEM; ∗significantly (𝑃 <
0.05) different from periodontally healthy donors.
was also observed in the subepithelial connective tissue,
where immunostaining was found in the cytoplasm of fibrob-
lasts and endothelial cells as well as in the extracellular space
(Figure 4(f)).
4. Discussion
The present study provides original evidence that HGF pro-
duce NAMPT, and this synthesis is stimulated by the proin-
flammatory cytokine IL-1𝛽 and the periodontopathogens P.
gingivalis and F. nucleatum. These findings suggest that local
synthesis of NAMPT in the inflamed gingiva may contribute
to the enhanced gingival and serum levels of NAMPT, as
observed in patients with periodontitis.The local production
of NAMPT by periodontal cells may represent a possible
mechanism whereby periodontitis may impact on systemic
diseases, such as diabetes mellitus and cardiovascular dis-
eases. Moreover, since NAMPT stimulates the synthesis of
proinflammatory andmatrix-degradingmolecules, increased
NAMPT production by HGF at inflamed sites may result in
the amplification of periodontal inflammation and destruc-
tion.
In a subset of experiments, we also studied the expres-
sion of adiponectin, leptin, and resistin in HGF. Although
these adipokines could also be detected by real-time PCR,
their expressions were very slight and barely modulated.
A few studies have reported that HGF express AdipoR1
and AdipoR2, but not adiponectin, which seems to be in
contrast to our findings [28, 29]. However, in these studies,
the expression of adiponectin was analyzed by end-point
PCR and immunoblotting, but not real-time PCR, which is
a highly sensitive and quantitative assay. In our study, the
constitutive expression of adiponectin was almost 200-fold
less than that of NAMPT. Therefore, the aforementioned
studiesmaywell concurwith our observation that production
of adiponectin by HGF is negligible. In one study, the
presence of leptin and its receptor in gingival tissue was
studied by immunohistochemistry [30]. Leptin and its recep-
tor were found in epithelial, endothelial, and inflammatory
cells, but not subepithelial fibroblasts. In the present study,
the constitutive expression of leptin was 1000-fold less than
the expression of NAMPT. Therefore, the observations by
Ay et al. [30] may also be in line with our findings that leptin
production byHGFmay not be significant. As far as we know,
there are no reports about the presence of resistin in HGF so
far.
In the present study, HGF were exposed to IL-1𝛽, which
was used to mimic inflammatory conditions in vitro, as in
our previous studies [25–27].This proinflammatory cytokine
has been shown to be increased in GCF and gingival tissues
at inflamed sites [31–33]. In order to simulate a microbial
environment in vitro, HGF were treated with a suspension of
P. gingivalis and F. nucleatum. The suspensions were exposed
to intensive ultrasonication and contained disrupted cell
wall particles with a high amount of lipopolysaccharide.
Nevertheless, other microbial components may also have
been present in the suspensions. P. gingivalis, which is a
gram-negative bacterium and strongly linked to periodon-
titis, possesses various virulence factors, such as gingipains
and fimbriae. This bacterium has been shown to invade
host cells and evade the host defense system [34–36]. F.
nucleatum is also a gram-negative, anaerobicmicroorganism.
This bacterium acts as a bridge bacterium between early and
late colonizers during plaque development and is associated
with both gingivitis and periodontitis. Like P. gingivalis, F.
nucleatum has also been demonstrated to invade host cells
[37–42]. Nonetheless, periodontal diseases are caused by a
complex bacterial biofilm and further studies should clarify
whether other microorganisms, which are associated with
periodontitis, also stimulate the synthesis of NAMPT in
HGF. In order to ensure that data were comparable, IL-1𝛽, P.
gingivalis, and F. nucleatumwere applied at the same doses as
in previous studies [22, 23].
Our findings for NAMPT at transcriptional levels were
paralleled by the findings obtained by ELISA. IL-1𝛽 and the
periodontopathogens P. gingivalis and F. nucleatum caused
increased NAMPT levels in the supernatants of the stimu-
lated cells. In general, the ELISA results were also in agree-
ment with findings from the immunocytochemistry analysis,
which demonstrated increased NAMPT protein levels in IL-
1𝛽- and F. nucleatum-stimulated cells, as compared to control.
However, in contrast to the ELISAdata, only slight differences
in NAMPT protein levels were found between P. gingivalis-
treated and control cells by immunocytochemistry. Whether
P. gingivalis leads to a fast and almost complete secretion of
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Figure 4: NAMPT protein levels in gingival biopsies. Gingiva from periodontally healthy ((a) and (d)), gingivitis ((b) and (e)), and
periodontitis ((c) and (f)) subjects. Hematoxylin and eosin stain ((a)–(c)). NAMPT protein, as demonstrated by immunohistochemistry
((d)–(f)). Images from one representative individual of each group are shown. GE: gingival epithelium; CT: connective tissue, GF: fibroblast;
EC: endothelial cell.
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NAMPT in HGF or whether other mechanisms play a role
needs to be determined in further studies.
We also sought to unravel the intracellular mechanisms
underlying the upregulation of NAMPT in HGF. Our exper-
iments revealed that the F. nucleatum-induced NAMPT
upregulationwas dependent onMEK1/2 andNF𝜅B signaling.
These results are in line with our previous findings on PDL
cells, in which the NF𝜅B pathway was also activated by F.
nucleatum [22]. Further studies should examine what path-
ways are used by IL-1𝛽 and P. gingivalis for their stimulatory
effects on NAMPT expression.
In order to verify the results from our in vitro experi-
ments, inwhich inflammatory and infectious conditionswere
simulated, we also studied the expression and protein levels
of NAMPT in gingival biopsies from periodontally healthy,
gingivitis, and periodontitis subjects. To our knowledge,
this is the first study which demonstrates that the gingival
expression of NAMPT is increased at sites of periodontitis as
compared to healthy sites. This finding is in accordance with
our in vitro results, which revealed that NAMPT expression
and protein levels are increased under inflammatory and
infectious conditions. However, gingival biopsies contain
various cell types, such as fibroblasts, epithelial, endothelial,
and inflammatory cells, and each of themmight be a possible
source of NAMPT. We therefore also studied the production
of NAMPT in gingival tissue by immunohistochemistry.
Whereas no or only very low levels of NAMPT were found
in the subepithelial connective tissue of healthy gingival
biopsies, high amounts of NAMPT were observed in the
connective tissue of gingiva from periodontitis patients.
Immunostaining for NAMPT was detected in the cytoplasm
of fibroblasts and endothelial cells as well as in the extra-
cellular space. Interestingly, NAMPT was also present in
epithelial cells in both healthy and diseased tissues. These
results confirm our in vitro data on the increased NAMPT
production in gingival fibroblasts under inflammatory and
infectious conditions. Furthermore, our data provide first
evidence that gingival epithelial cells produce NAMPT.
We also sought to examine the expression of other
adipokines in gingival biopsies. Our study shows for the
first time that the proinflammatory adipokine resistin is
also significantly upregulated in inflamed gingival tissue as
compared to healthy gingiva. By contrast, the leptin and
adiponectin expressions were decreased in gingiva from
periodontitis patients. The downregulation of these two
adipokines was paralleled by the upregulation of their recep-
tors in periodontitis. In a recent study, the expression of both
adiponectin receptors was lower in periodontal tissues from
patients with severe periodontitis than in healthy periodontal
tissues [43]. It was therefore speculated that adiponectin may
not function efficiently at sites of periodontitis due to the
decrease in the number of its receptors. However, this study
only included a small number of individuals. Furthermore,
immunoblotting was used in contrast to our study, where
real-time PCR analysis was performed. One study focused
on leptin protein levels in gingiva from healthy sites and
sites of gingivitis or periodontitis [44]. This study showed a
significant decrease in the concentration of gingival leptin, as
analyzed by ELISA, and therefore concurs with our finding
at transcriptional level. Our findings are also supported by
another study, which demonstrated that leptin is present
within healthy and inflamed gingiva and decreases in con-
centration as the adjacent probing depth increases [45]. A
third study, in which an immunohistochemistry analysis was
performed, also demonstrated the presence of leptin and its
receptor in gingival tissue. However, no differences in tissue
staining distribution and intensity of leptin and its receptor
between healthy and inflamed periodontal conditions were
found, which might be due to the less sensitive assay used in
this study [30].
In summary, the present study provides original evidence
that gingival fibroblasts produce NAMPT and that this
synthesis is increased under inflammatory and infectious
conditions. Local synthesis of NAMPT in the inflamed
gingiva may contribute to the enhanced gingival and serum
levels of NAMPT, as observed in periodontitis patients.
Moreover, local production ofNAMPTby gingival fibroblasts
may represent a possible mechanism whereby periodontitis
may impact on systemic diseases.
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